SEC-sourced researchBeta

ACON

Aclarion, Inc.

US markets

Data passport

CIK: 0001635077
Exchange: Nasdaq
Business activity: Services-Medical Laboratories · SIC 8071
Financial inputs: 6/6
Filing date: Aug 19, 2026
SEC registry record: Operating company

Last updated: Oct 8, 2026, 9:09 AM UTCSEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Chart metric

ACON · Exact amounts and source periods · USD
Period end	Revenue	Filing date
December 2024	45,724.0000	Mar 18, 2026
December 2025	75,730.0000	Mar 18, 2026

Annual periods · USD

Period end	Revenue	Net income	Operating cash flow	Total assets	Total liabilities	Filing date
December 2025	75,730.0000	-7,233,629.0000	-7,164,204.0000	13,672,404.0000	837,287.0000	Mar 18, 2026
December 2024	45,724.0000	-6,992,927.0000	-5,271,609.0000	2,123,483.0000	1,153,426.0000	Mar 18, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

59/100

Profitability0

Growth100

Balance sheet94

Cash generation0

Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputs	USD	Period end	Filing date	Form
RevenueRevenues	$75.73K	Jan 1, 2025 – Dec 31, 2025	Mar 18, 2026	10-K
Previous period revenueRevenues	$45.72K	Jan 1, 2024 – Dec 31, 2024	Mar 18, 2026	10-K
Net incomeNetIncomeLoss	-$7.23M	Jan 1, 2025 – Dec 31, 2025	Mar 18, 2026	10-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities	-$7.16M	Jan 1, 2025 – Dec 31, 2025	Mar 18, 2026	10-K
Total assetsAssets	$13.67M	Dec 31, 2025	Mar 18, 2026	10-K
Total liabilitiesLiabilities	$837.29K	Dec 31, 2025	Mar 18, 2026	10-K

New filings

Explore methodology ↗